GILD:NGS-Gilead Sciences Inc. (USD)

EQUITY | Drug Manufacturers - General | Nasdaq Global Select

Last Closing

USD 69.31

Change

-0.30 (-0.43)%

Market Cap

USD 98.10B

Volume

5.40M
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Gilead Sciences Inc is a research-based biopharmaceutical company that discovers, develops and commercializes new medicines for different medical sectors.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-26 )

Largest Industry Peers for Drug Manufacturers - General

Symbol Name Price(Change) Market Cap
AZN AstraZeneca PLC ADR

N/A

USD 241.92B
AMGN Amgen Inc

N/A

USD 173.38B
SNY Sanofi ADR

N/A

USD 144.83B
BIIB Biogen Inc

N/A

USD 28.36B
GRFS Grifols SA ADR

N/A

USD 7.13B
AMRN Amarin Corporation PLC

N/A

USD 0.25B
MIRA MIRA Pharmaceuticals, Inc. Com..

N/A

USD 0.02B
SCLX Scilex Holding Company

N/A

N/A
SCLXW Scilex Holding Company

N/A

N/A

ETFs Containing GILD

2B70:F iShares NASDAQ US Biotech.. 9.35 % 0.00 %

N/A

USD 0.52B
2B70:XETRA iShares Nasdaq US Biotech.. 9.35 % 0.00 %

N/A

USD 0.52B
BBH VanEck Biotech ETF 9.20 % 0.35 %

N/A

USD 0.45B
IBBQ Invesco Nasdaq Biotechnol.. 8.64 % 0.00 %

N/A

USD 0.04B
IBB iShares Biotechnology ETF 8.62 % 0.47 %

N/A

USD 7.60B
BTEC:SW iShares Nasdaq US Biotech.. 8.25 % 0.00 %

N/A

N/A
UBIO 7.77 % 0.95 %

N/A

N/A
BIS ProShares UltraShort Nasd.. 7.41 % 0.95 %

N/A

USD 3.74M
BIB ProShares Ultra Nasdaq Bi.. 6.16 % 0.95 %

N/A

USD 0.09B
FHI-B:CA CI Health Care Giants Cov.. 5.19 % 0.00 %

N/A

CAD 0.05B
HDLB ETRACS Monthly Pay 2xLeve.. 5.14 % 0.00 %

N/A

USD 8.59M
IDNA iShares Genomics Immunolo.. 4.78 % 0.00 %

N/A

USD 0.14B
XDNA:CA iShares Genomics Immunolo.. 4.78 % 0.00 %

N/A

CAD 5.07M
XSFD:LSE Xtrackers S&P Select Fron.. 4.32 % 0.00 %

N/A

USD 0.09B
XSFR:LSE Xtrackers S&P Select Fron.. 4.32 % 0.00 %

N/A

USD 0.09B
DX2Z:XETRA Xtrackers - S&P Select Fr.. 4.32 % 0.00 %

N/A

USD 0.10B
UDI USCF ETF Trust 4.00 % 0.00 %

N/A

N/A
JPHC:PA Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 4.41M
JP40:XETRA Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 0.05B
JPHG:PA Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

N/A
JPHC:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 4.45M
JPHE:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 0.08B
JPHG:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 3.73M
JPHU:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 0.05B
JPNK:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 0.07B
JPNY:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 5.83B
TBG EA Series Trust 3.83 % 0.00 %

N/A

USD 0.06B
FBT:LSE First Trust Global Funds .. 3.70 % 0.00 %

N/A

USD 7.86M
FBTU:LSE First Trust Global Funds .. 3.70 % 0.00 %

N/A

USD 7.86M
CBUF:XETRA iShares MSCI World Health.. 3.50 % 0.00 %

N/A

USD 1.13B
CBUF:F iShares V Public Limited .. 3.37 % 0.00 %

N/A

N/A
MDLV 3.19 % 0.00 %

N/A

N/A
WHCS:SW iShares MSCI World Health.. 3.19 % 0.00 %

N/A

N/A
CURE:AU ETFS S&P Biotech ETF 3.08 % 0.00 %

N/A

USD 0.04B
MOTU:LSE VanEck Morningstar US Wid.. 2.82 % 0.00 %

N/A

USD 0.05B
MOTV:LSE VanEck Morningstar US Wid.. 2.81 % 0.00 %

N/A

USD 0.05B
SIXA 6 Meridian Mega Cap Equit.. 2.76 % 0.00 %

N/A

USD 0.28B
SIXH ETC 6 Meridian Hedged Equ.. 2.76 % 0.00 %

N/A

USD 0.43B
MOAT:AU VanEck Morningstar Wide M.. 2.64 % 0.00 %

N/A

USD 0.93B
MHOT:AU VanEck Morningstar Wide M.. 2.54 % 0.00 %

N/A

N/A
WMOT:XETRA VanEck Morningstar US Wid.. 2.51 % 0.00 %

N/A

N/A
XDGI:XETRA Xtrackers MSCI Global SDG.. 2.26 % 0.00 %

N/A

USD 0.02B
WTD9:F WisdomTree US Equity Inco.. 2.16 % 0.00 %

N/A

USD 0.06B
WTDY:F WisdomTree Issuer ICAV - .. 2.16 % 0.00 %

N/A

USD 1.58M
WTEU:F WisdomTree US Equity Inco.. 2.16 % 0.00 %

N/A

USD 0.11B
WTD9:XETRA WisdomTree Issuer ICAV - .. 2.16 % 0.00 %

N/A

USD 0.05B
WTDY:XETRA WisdomTree Issuer ICAV - .. 2.16 % 0.00 %

N/A

USD 0.85M
WTEU:XETRA WisdomTree US Equity Inco.. 2.16 % 0.00 %

N/A

USD 0.11B
TDOC:CA TD Global Healthcare Lead.. 2.12 % 0.00 %

N/A

CAD 0.09B
DHS:SW WisdomTree US Equity Inco.. 2.04 % 0.00 %

N/A

N/A
DHSA:SW WisdomTree US Equity Inco.. 2.04 % 0.00 %

N/A

N/A
BBP Virtus LifeSci Biotech Pr.. 1.96 % 0.79 %

N/A

USD 0.02B
2B78:XETRA iShares Healthcare Innova.. 1.83 % 0.00 %

N/A

USD 1.14B
2B78:F iShares Healthcare Innova.. 1.83 % 0.00 %

N/A

N/A
RSPH Invesco S&P 500® Equal.. 1.81 % 0.00 %

N/A

USD 1.02B
HEAL:SW iShares Healthcare Innova.. 1.73 % 0.00 %

N/A

N/A
LABU Direxion Daily S&P Biotec.. 1.71 % 1.14 %

N/A

USD 0.94B
WEBA:XETRA Amundi US Tech 100 Equal .. 1.17 % 0.00 %

N/A

USD 0.61B
EVO:CA Evovest Global Equity ETF 0.96 % 0.00 %

N/A

N/A
WELE:XETRA Amundi S&P 500 Equal Weig.. 0.59 % 0.00 %

N/A

N/A
FVD:LSE First Trust Value Line® .. 0.52 % 0.00 %

N/A

USD 0.02B
UBBB:PA Amundi Index Solutions - .. 0.46 % 0.00 %

N/A

USD 0.13B
XEWE:XETRA Xtrackers S&P 500 Equal W.. 0.41 % 0.00 %

N/A

USD 1.70B
BSCK 0.00 % 0.10 %

N/A

N/A
BSCL 0.00 % 0.10 %

N/A

N/A
BSCQ Invesco BulletShares 2026.. 0.00 % 0.10 %

N/A

N/A
CBND 0.00 % 0.16 %

N/A

N/A
DVP 0.00 % 0.48 %

N/A

N/A
ESGW 0.00 % 0.40 %

N/A

N/A
FCY 0.00 % 0.84 %

N/A

N/A
FCY:CA 0.00 % 0.95 %

N/A

N/A
FDL First Trust Morningstar D.. 0.00 % 0.45 %

N/A

N/A
FLAG 0.00 % 1.52 %

N/A

N/A
IBCD 0.00 % 0.10 %

N/A

N/A
MOAT 0.00 % 0.49 %

N/A

N/A
ONEV SPDR® Russell 1000 Low V.. 0.00 % 0.20 %

N/A

N/A
ONEY SPDR® Russell 1000® Yie.. 0.00 % 0.20 %

N/A

N/A
PBE Invesco Dynamic Biotechno.. 0.00 % 0.57 %

N/A

N/A
FTXH First Trust Nasdaq Pharma.. 0.00 % 0.60 %

N/A

USD 0.02B
IVFVC 0.00 % 0.00 %

N/A

N/A
VSL 0.00 % 0.65 %

N/A

N/A
FHI:CA CI Health Care Giants Cov.. 0.00 % 0.75 %

N/A

CAD 0.07B
JIGB 0.00 % 0.14 %

N/A

N/A
SPBO SPDR Portfolio Corporate .. 0.00 % 0.00 %

N/A

USD 1.68B
BTEC:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

N/A

N/A
BTEK:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

N/A

N/A
BTEE:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

N/A

N/A
RJZ 0.00 % 0.75 %

N/A

N/A
SCIU 0.00 % 0.19 %

N/A

N/A
SDOG ALPS Sector Dividend Dogs.. 0.00 % 0.40 %

N/A

USD 1.23B
SICK 0.00 % 0.95 %

N/A

N/A
XBI SPDR® S&P Biotech ETF 0.00 % 0.35 %

N/A

N/A
XMS:CA iShares Edge MSCI Min Vol.. 0.00 % 0.33 %

N/A

N/A
ZBIO Zenas BioPharma, Inc. Com.. 0.00 % 0.95 %

N/A

N/A
FCW:CA 0.00 % 0.90 %

N/A

N/A
SPDV AAM S&P 500 High Dividend.. 0.00 % 0.29 %

N/A

USD 0.06B
DHS:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

N/A
DHSA:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

N/A
DHSD:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

N/A
DHSG:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

N/A
DHSP:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

N/A
DRDR:LSE iShares Healthcare Innova.. 0.00 % 0.00 %

N/A

N/A
HEAL:LSE iShares Healthcare Innova.. 0.00 % 0.00 %

N/A

N/A
MINV:LSE iShares VI Public Limited.. 0.00 % 0.00 %

N/A

N/A
MVOL:LSE iShares Edge MSCI World M.. 0.00 % 0.00 %

N/A

N/A
XFVT:LSE Xtrackers FTSE Vietnam Sw.. 0.00 % 0.00 %

N/A

N/A
JP40:F Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

N/A
JP4H:F Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

N/A
JP4H:XETRA 0.00 % 0.00 %

N/A

N/A
ZGEN:CA 0.00 % 0.00 %

N/A

N/A
ZINN:CA 0.00 % 0.00 %

N/A

N/A
GOAT:AU VanEck Morningstar World .. 0.00 % 0.00 %

N/A

USD 0.04B
SCHJ Schwab 1-5 Year Corporate.. 0.00 % 0.00 %

N/A

N/A
HDIV 0.00 % 0.00 %

N/A

N/A
GDOC Goldman Sachs ETF Trust 0.00 % 0.00 %

N/A

USD 0.02B
CSY9:XETRA UBS (Irl) ETF plc - Facto.. 0.00 % 0.00 %

N/A

USD 0.29B
WDMVO:SW UBS (Irl) ETF plc - Facto.. 0.00 % 0.00 %

N/A

USD 0.30B

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - General) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -14.44% 50% F 36% F
Dividend Return 1.90% 75% C 62% D
Total Return -12.54% 60% D- 37% F
Trailing 12 Months  
Capital Gain -9.02% 78% C+ 44% F
Dividend Return 2.02% 25% F 33% F
Total Return -7.00% 67% D+ 45% F
Trailing 5 Years  
Capital Gain 2.59% 57% F 58% F
Dividend Return 18.92% 60% D- 77% C+
Total Return 21.51% 57% F 62% D
Average Annual (5 Year Horizon)  
Capital Gain 2.84% 78% C+ 53% F
Dividend Return 6.68% 78% C+ 60% D-
Total Return 3.84% 100% F 76% C+
Risk Return Profile  
Volatility (Standard Deviation) 17.71% 67% D+ 80% B-
Risk Adjusted Return 37.72% 67% D+ 70% C-
Market Capitalization 98.10B 67% D+ 99% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Drug Manufacturers - General) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 7.00 14% 7%
Price/Book Ratio 3.72 44% 29%
Price / Cash Flow Ratio 10.00 78% 25%
Price/Free Cash Flow Ratio 9.78 67% 27%
Management Effectiveness  
Return on Equity 2.39% 38% 62%
Return on Invested Capital 18.80% 80% 87%
Return on Assets 10.50% 100% 95%
Debt to Equity Ratio 101.93% 38% 22%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced on cashflow basis

The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.